BRONCHIOLITIS OBLITERANS SYNDROME
Clinical trials for BRONCHIOLITIS OBLITERANS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS SYNDROME trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope to halt lung damage after Life-Saving transplants
Disease control Recruiting nowThis study is testing a drug called belumosudil to see if it can help control a serious lung scarring condition called bronchiolitis obliterans syndrome (BOS). BOS can develop in people who have received a donor stem cell transplant. The trial will enroll 45 adults who have eithe…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 03, 2026 22:26 UTC
-
New breath-hold scan aims to spot hidden lung damage in transplant kids
Diagnosis Recruiting nowThis study is testing if a special type of MRI scan, where children hold their breath while inhaling a safe gas, can help doctors spot a serious lung condition earlier. The condition, called bronchiolitis obliterans syndrome, can happen after a child receives a stem cell transpla…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Sponsor: The Hospital for Sick Children • Aim: Diagnosis
Last updated Apr 02, 2026 14:56 UTC
-
Scientists track viruses to unlock cause of devastating transplant lung disease
Knowledge-focused Recruiting nowThis study aims to understand if respiratory viruses cause a serious lung disease called bronchiolitis obliterans syndrome (BOS) in people who have received a donor stem cell transplant. Researchers will follow 250 patients at risk for or already diagnosed with BOS for up to two …
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC